Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

  title={Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.},
  author={Gerrit Jan Laarman and Maarten Jan Suttorp and Maurits T. Dirksen and Loek van Heerebeek and Ferdinand Kiemeneij and Ton Slagboom and L Ron van der Wieken and Jan G. P. Tijssen and Benno J.W.M. Rensing and Mark S. Patterson},
  journal={The New England journal of medicine},
  volume={355 11},
BACKGROUND Drug-eluting coronary-artery stents have been shown to decrease restenosis and therefore the likelihood that additional procedures will be required after percutaneous coronary intervention (PCI). We evaluated the use of a drug-eluting stent in patients undergoing PCI for acute myocardial infarction with ST-segment elevation. METHODS We randomly assigned 619 patients presenting with an acute myocardial infarction with ST-segment elevation to receive either a paclitaxel-eluting stent… CONTINUE READING
159 Citations
20 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 159 extracted citations


Publications referenced by this paper.
Showing 1-10 of 20 references

BASKET-LATE trial. Presented at the 55th Annual Scientific Session of the American College of Cardiology, Atlanta

  • ME Pfisterer
  • 2006

Short - and long - term clinical benefit of sirolimus - eluting stents compared to conventional bare stents for patients with acute myocardial infarction

  • E Cheneau, SW Rha, PK Kuchulakanti
  • J Am Coll Cardiol
  • 2004

Prima - ry angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials

  • E Boersma
  • Lancet
  • 2003

Similar Papers

Loading similar papers…